Cover Image

Sarcoma European and Latin American Network (SELNET) recommendations on prioritization in Sarcoma Care During the COVID‐19 Pandemic

The COVID‐19 outbreak has resulted in collision between patients infected with SARS‐CoV‐2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. Adaptive measures to minimize hospital exposure, following the precau...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin-Broto, Javier (Author) , Hindi, Nadia (Author) , Aguiar, Samuel, Jr (Author) , Badilla‐González, Ronald (Author) , Castro‐Oliden, Victor (Author) , Chacón, Matias (Author) , Correa‐Generoso, Raquel (Author) , Álava, Enrique (Author) , Donati, Davide María (Author) , Eriksson, Mikael (Author) , Falla‐Jimenez, Martin (Author) , German, Gisela (Author) , Gobo Silva, Maria Leticia (Author) , Gouin, Francois (Author) , Gronchi, Alessandro (Author) , Haro‐Varas, Juan Carlos (Author) , Jiménez‐Brenes, Natalia (Author) , Kasper, Bernd (Author) , Lopes de Mello, Celso Abdon (Author) , Maki, Robert (Author) , Martínez‐Delgado, Paula (Author) , Martínez‐Said, Hector (Author) , Martinez‐Tlahuel, Jorge Luis (Author) , Morales‐Pérez, Jose Manuel (Author) , Muñoz‐Casares, Francisco Cristobal (Author) , Nakagawa, Suely A. (Author) , Ortiz‐Cruz, Eduardo Jose (Author) , Palmerini, Emanuela (Author) , Patel, Shreyaskumar (Author) , Moura, David S. (Author) , Stacchiotti, Silvia (Author) , Sunyach, Marie Pierre (Author) , Valverde, Claudia M. (Author) , Waisberg, Federico (Author) , Blay, Jean‐Yves (Author)
Format: Article (Journal)
Language:English
Published: October 2020
In: The oncologist
Year: 2020, Volume: 25, Issue: 10, Pages: e1562-e1573
ISSN:1549-490X
DOI:10.1634/theoncologist.2020-0516
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1634/theoncologist.2020-0516
Verlag, kostenfrei, Volltext: https://academic.oup.com/oncolo/article/25/10/e1562/6443985
Get full text
Author Notes:Javier Martin‐Broto, Nadia Hindi, Samuel, Jr Aguiar, Ronald Badilla‐González, Victor Castro‐Oliden, Matias Chacón, Raquel Correa‐Generoso, Enrique Álava, Davide María Donati, Mikael Eriksson, Martin Falla‐Jimenez, Gisela German, Maria Leticia Gobo Silva, Francois Gouin, Alessandro Gronchi, Juan Carlos Haro‐Varas, Natalia Jiménez‐Brenes, Bernd Kasper, Celso Abdon Lopes de Mello, Robert Maki, Paula Martínez‐Delgado, Hector Martínez‐Said, Jorge Luis Martinez‐Tlahuel, Jose Manuel Morales‐Pérez, Francisco Cristobal Muñoz‐Casares, Suely A. Nakagawa, Eduardo Jose Ortiz‐Cruz, Emanuela Palmerini, Shreyaskumar Patel, David S. Moura, Silvia Stacchiotti, Marie Pierre Sunyach, Claudia M. Valverde, Federico Waisberg, Jean‐Yves Blay
Description
Summary:The COVID‐19 outbreak has resulted in collision between patients infected with SARS‐CoV‐2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. Adaptive measures to minimize hospital exposure, following the precautionary principle, have been proposed for cancer care during COVID‐19 era. We present here a consensus on prioritizing recommendations across the continuum of sarcoma patient care.A total of 125 recommendations were proposed in soft‐tissue, bone, and visceral sarcoma care. Recommendations were assigned as higher or lower priority if they cannot or can be postponed at least 2-3 months, respectively. The consensus level for each recommendation was classified as “strongly recommended” (SR) if more than 90% of experts agreed, “recommended” (R) if 75%-90% of experts agreed and “no consensus” (NC) if fewer than 75% agreed. Sarcoma experts from 11 countries within the Sarcoma European‐Latin American Network (SELNET) consortium participated, including countries in the Americas and Europe. The European Society for Medical Oncology‐Magnitude of clinical benefit scale was applied to systemic‐treatment recommendations to support prioritization.There were 80 SRs, 35 Rs, and 10 NCs among the 125 recommendations issued and completed by 31 multidisciplinary sarcoma experts. The consensus was higher among the 75 higher‐priority recommendations (85%, 12%, and 3% for SR, R, and NC, respectively) than in the 50 lower‐priority recommendations (32%, 52%, and 16% for SR, R, and NC, respectively).The consensus on 115 of 125 recommendations indicates a high‐level of convergence among experts. The SELNET consensus provides a tool for sarcoma multidisciplinary treatment committees during the COVID‐19 outbreak.
Item Description:Gesehen am 08.09.2025
Physical Description:Online Resource
ISSN:1549-490X
DOI:10.1634/theoncologist.2020-0516

Similar Items